[Hepatic angiosarcoma: a report of a case associated with treatment with arsenic salts and a review of the literature]

Gastroenterol Hepatol. 1995 Mar;18(3):132-5.
[Article in Spanish]

Abstract

Hepatic angiosarcoma is an infrequent neoplasm representing 1-3% of all the primary liver cancers. One fourth of the cases have demonstrated a relation with chemical carcinogens with the most frequent being thorium dioxide (thorotrast) and vinyl chloride. The case of an hepatic angiosarcoma which presented as an intraperitoneal hemorrhage in a patient who had undergone treatment with Neosalvarsán (dioxidiaminoarsenobenzol) 46 years beforehand is reported. The previous published reports include 6 cases of hepatic angiosarcoma related with treatment with arsenic salts and 4 cases in whom exposure was environmental.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Arsenicals / adverse effects*
  • Arsphenamine / adverse effects
  • Arsphenamine / analogs & derivatives*
  • Biopsy
  • Fatal Outcome
  • Hemangiosarcoma / chemically induced*
  • Hemangiosarcoma / complications
  • Hemangiosarcoma / diagnosis
  • Hemoperitoneum / diagnosis
  • Hemoperitoneum / etiology
  • Humans
  • Liver / pathology
  • Liver Neoplasms / chemically induced*
  • Liver Neoplasms / complications
  • Liver Neoplasms / diagnosis
  • Male
  • Middle Aged
  • Shock / diagnosis
  • Shock / etiology
  • Syphilis / drug therapy
  • Time Factors

Substances

  • Arsenicals
  • Arsphenamine
  • neoarsphenamine